This study also showed that the concentrations of IL-6, IL-17 and IL-23 were all significantly higher in CLL patients, while concentrations of TGF-β1 and IL-10 were clearly lower than controls. The gene discussed is IL6; the disease is B-cell chronic lymphocytic leukemia.